» Articles » PMID: 31396944

Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis

Overview
Date 2019 Aug 10
PMID 31396944
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Facial seborrheic dermatitis (FSD) is a chronic and relapsing inflammatory skin disorder occurring in areas of the face rich in sebaceous glands. It clinically manifests as erythematous scaly macules or plaques, often associated with pruritus. Although the pathogenesis of seborrheic dermatitis is not yet fully understood, Malassezia yeast, hormones, sebum levels, and immune response are known to play important roles. Additional factors including drugs, cold temperatures, and stress may exacerbate the condition. Currently, the available treatments do not cure the disease but relieve symptoms. Various pharmacological treatments are available, including antifungal agents, keratolytics, topical low-potency steroids, and calcineurin inhibitors. All of them provide several benefits, but they also have potential side effects. Seborrheic dermatitis tends to have a chronic, recurrent course. To avoid the long-term use of drugs, topical non-pharmacological products such as cosmetics or medical devices may improve clinical outcomes. Products with antimicrobial and anti-inflammatory ingredients such as zinc, piroctone olamine, dihydroavenanthramide, biosaccharide gum-2, and stearyl glycyrrhetinate may speed FSD recovery and avoid flare-ups. Finally, the use of specific cleansers, moisturizers, and sunscreens formulated as light creams or gel/creams should be strongly recommended to all FSD patients. We provide a brief review of the most used non-pharmacological cleansers, topical gel/creams, and specific sunscreens in the management of FSD.

Citing Articles

A Cohort Clinical Study on the Efficacy of Topical Salicylic Acid/Piroctone Olamine Dandruff Pre-Gel and Cleanser in Improving Symptoms of Moderate to Severe Seborrheic Dermatitis of the Scalp.

Ge L, Liu Z, Xu S, Li C, Jin M, Luo Y J Cosmet Dermatol. 2025; 24(1):e16742.

PMID: 39778065 PMC: 11705510. DOI: 10.1111/jocd.16742.


Pseudohyperaldosteronism Due to Licorice: A Practice-Based Learning from a Case Series.

Sabbadin C, Graziani A, Bavaresco A, Mazzeo P, Tizianel I, Ceccato F Int J Mol Sci. 2024; 25(13).

PMID: 39000561 PMC: 11242244. DOI: 10.3390/ijms25137454.


Promoting public skin health through a national continuing medical education project on cosmetic and dermatologic sciences: a 15-year experience.

Li Y, Shu X, Huo W, Wang X Front Public Health. 2023; 11:1273950.

PMID: 38035281 PMC: 10687160. DOI: 10.3389/fpubh.2023.1273950.


Tea Tree Oil: Properties and the Therapeutic Approach to Acne-A Review.

Nascimento T, Gomes D, Simoes R, da Graca Miguel M Antioxidants (Basel). 2023; 12(6).

PMID: 37371994 PMC: 10295805. DOI: 10.3390/antiox12061264.


[Piroctone olamine disrupts mitochondrial dynamics in glioma cells through the PI3K/AKT pathway].

Xu W, Ye J, Wang F, Chen T Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(5):764-771.

PMID: 37313818 PMC: 10267238. DOI: 10.12122/j.issn.1673-4254.2023.05.12.


References
1.
Rostan E, DeBuys H, Madey D, Pinnell S . Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol. 2002; 41(9):606-11. DOI: 10.1046/j.1365-4362.2002.01567.x. View

2.
Thiboutot D, Jabara S, McAllister J, Sivarajah A, Gilliland K, Cong Z . Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol. 2003; 120(6):905-14. DOI: 10.1046/j.1523-1747.2003.12244.x. View

3.
Gupta A, Madzia S, Batra R . Etiology and management of Seborrheic dermatitis. Dermatology. 2004; 208(2):89-93. DOI: 10.1159/000076478. View

4.
Maietta G, Rongioletti F, Rebora A . Seborrheic dermatitis and daylight. Acta Derm Venereol. 1991; 71(6):538-9. View

5.
Lang C, Murgia C, Leong M, Tan L, Perozzi G, Knight D . Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation. Am J Physiol Lung Cell Mol Physiol. 2006; 292(2):L577-84. DOI: 10.1152/ajplung.00280.2006. View